Evis Drenova (@evisdrenova)
@evisdrenova
Principal Eng @ Entire | prev. co-founder @ Neosync (acq. Grow Therapy) @ycombinator @uchicago
922 正在关注 4.4K 粉丝
One fascinating consequence of GLP-1s/Ozempic:
For decades, people said that big pharma would never release actually effective obesity drugs because they’d lose too much money from downstream chronic disease treatment.
We’re seeing almost the exact opposite.
显示更多
